1 Product identity
Ingredient risk
1 ingredient to use with caution
Lipo6X
BrandNutrex Research Basix Series→Non-Nutrient/Non-Botanical Capsule 9 ingredients 1 caution DSLD #176257Net contents: 120 Multi-Phase Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2018-08-31
2 Ingredients (9)
IngredientGroupSafety
Hordenine HClHordenine—
SynephrineSynephrine—
Yohimbine HClYohimbine—
RauwolscineRauwolscine—
Vegetable Cellulose Capsulecapsule—
GlycerinGlycerol—
purified USP WaterWater—
FD&C Blue 2Color—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Caffeine (Anhydrous) 🇬🇧 🇪🇺 🇦🇺 — High caffeine warnings mandatory on products >150 mg/L.
3 Safety cross-reference
Caffeine (Anhydrous) — Use with Caution
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID176257
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2018-08-31
6 More from Nutrex Research Basix Series
Lipo-6 CarnitineLipo-6 CarnitineLipo6 CLALipo6 CLALipo6 CLALipo6 CLA7 Cite this page
Vancouver
Pkhakadze G. Lipo6X — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 30]. Available from: https://supplement.ge/products/lipo6x-176257/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG